Top News

Mar 06, 2015
BioPharm International
In a landmark decision, FDA approved Zarxio, making it the first biosimilar product in the United States.
Mar 06, 2015
The agency will employ a ring vaccination method similar to the one used to eradicate smallpox.
Mar 05, 2015
By BioPharm International Editors
AbbVie’s acquisition of Pharmacyclics establishes the combined company as an emerging leader in hematological oncology.
Mar 04, 2015
By BioPharm International Editors
Patheon cites expanded API services with acquisition of IRIX Pharmaceuticals.
Feb 11, 2015
The industry reacts to the departure of Commissioner Margaret Hamburg.
Feb 09, 2015
BioPharm International
The agency seeks public comment on information collection for biosimilars and interchangeable products.
Feb 05, 2015
By BioPharm International Editors
Margaret Hamburg announced on Feb. 5, 2015 that she will step down as FDA Commissioner after serving in the position for almost six years.
Feb 05, 2015
BioPharm International
The deal may offset billions of dollars in waning sales from Pfizer drugs slated to lose patent protection and provides Pfizer with a whole portfolio of biosimilar products.
Feb 02, 2015
BioPharm International
The 2016 White House Budget proposes a change to the data exclusivity period for biologics and the authority to influence drug pricing.
Jan 23, 2015
By BioPharm International Editors
New drugs submitted for approval in Europe have 18 months to comply with new elemental impurities guidelines.
native1_300x100
lorem ipsum